Literature DB >> 22879084

Neuro-psychological sequelae in HIV-negative cryptococcal meningitis after complete anti-fungal treatment.

Chang-Hung Chen1, Chiung-Chih Chang, Wen-Neng Chang, Nai-Wen Tsai, Chun-Chung Lui, Wei-Che Lin, Nai-Ching Chen, Ching Chen, Chi-Wei Huang, Cheng-Hsien Lu.   

Abstract

PURPOSES: The cognitive sequelae and influence of depression in patients with cryptococcal meningitis (CM) after complete anti-fungal treatment has not been completely surveyed in literature.
METHODS: Seventeen HIV-negative CM patients and 26 health y controls were enrolled in this prospective study. Neuro-psychological evaluation was performed to assess the attention, execution, speech and language, semantic and visuo-construction function, and depression. These were correlated with longitudinal magnetic resonance imaging (MRI) through the following checklists: dilated Virchow-Robin spaces, pseudo-cysts, intra-cerebral nodule or mass, meningeal enhancement, hydrocephalus, and hyper-intensity of white matter. For cognitive outcome measurement, initial clinical and biochemical markers were collected and analyzed.
RESULTS: The mean follow-up duration in CM patients was 69.6 months. They had impairments in attention, execution, speech and language, and visuo-construction function, while six (35%) patients fulfilled the depression criteria. Initial cryptococcal antigen titer was inversely correlated with block design score (ρ=-0.54, p<0.05), after adjustment for depression. Patients with two or more CM-related lesions (mean, 19.2; SD, 12.6) (p=0.04). CM with depression is highly associated with poor cognitive performance and higher likelihood of two or more lesions in MRI (likelihood ratio=6.012, p=0.014).
CONCLUSION: Cognitive deficits persist in CM patients even after complete treatment. The number of lesions plays an important role in cognitive performance and depression. Extensive involvement of the cognitive domains with wide radiographic presentations suggests a disseminated nature of cryptococcus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22879084

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  4 in total

1.  Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study.

Authors:  Renee Donahue Carlson; Melissa A Rolfes; Kate E Birkenkamp; Noeline Nakasujja; Radha Rajasingham; David B Meya; David R Boulware
Journal:  Metab Brain Dis       Date:  2014-01-09       Impact factor: 3.584

2.  HIV-Negative Cryptococcal Meningoencephalitis Results in a Persistent Frontal-Subcortical Syndrome.

Authors:  Katherine Traino; Joseph Snow; Lillian Ham; Angela Summers; Laura Segalà; Talia Shirazi; Nadia Biassou; Anil Panackal; Seher Anjum; Kieren A Marr; William C Kreisl; John E Bennett; Peter R Williamson
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

3.  Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis.

Authors:  Owen Dean; Seher Anjum; Terri Scott; Lillian Ham; Katherine Traino; Jing Wang; Sally Hunsberger; John H Powers; Kieren A Marr; Joseph Snow; Peter R Williamson
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.996

4.  CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis.

Authors:  Jintao Xu; Anutosh Ganguly; Jessica Zhao; Michel Ivey; Rafael Lopez; John J Osterholzer; Clifford S Cho; Michal A Olszewski
Journal:  mBio       Date:  2021-07-27       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.